HLA class II (DR and DQ) antigen associations in idiopathic dilated cardiomyopathy. Validation study and meta-analysis of published HLA association studies.

Ovid Technologies (Wolters Kluwer Health) - Tập 83 Số 2 - Trang 515-522 - 1991
John F. Carlquist1, Ronald L. Menlove2, Megan Murray3, John B. O’Connell4, Jeffrey L. Anderson5
1J F Carlquist Department of Internal Medicine, University of Utah, LDS Hospital, Salt Lake City 84143.
2R L Menlove Department of Internal Medicine, University of Utah, LDS Hospital, Salt Lake City 84143.
3M B Murray Department of Internal Medicine, University of Utah, LDS Hospital, Salt Lake City 84143.
4J B O'Connell Department of Internal Medicine, University of Utah, LDS Hospital, Salt Lake City 84143.
5J L Anderson Department of Internal Medicine, University of Utah, LDS Hospital, Salt Lake City 84143.

Tóm tắt

We previously reported antigen frequency differences for HLA-DR4 and HLA-DRw6 between idiopathic dilated cardiomyopathy (IDC) patients and healthy controls in a pilot study. To confirm these findings, we undertook an independent study with a prospective hypothesis regarding the frequencies of DR4 and DRw6; typing for a second family of class II antigens (HLA-DQ) was included because of the proximity of the DQ loci to the DR loci and the strong linkage disequilibrium between some of the DR and DQ alleles. Comparing a new consecutive series of IDC patients (n = 41) and healthy blood bank controls (n = 53), we confirmed an increase of DR4 antigen frequency in patients (49% versus 21%, p less than 0.005). A trend toward decreased expression of DRw6 among patients was also noted (10% of patients versus 23% of controls). HLA-DQw4 was significantly elevated in patients compared with controls (27% versus 6%, p less than 0.005; relative risk, 6.1; etiologic fraction, 0.22). We identified the combined DR4-DQw4 haplotype in five of 41 Caucasian IDC patients (12%) and none of 53 controls (p less than 0.007). A comparison of specific antigen frequencies between the preliminary and validation studies did not reveal significant differences; therefore, the data from the two studies were examined in combination. For the combined studies, DR4 was elevated (51% versus 27% in controls, p less than 0.001), and DRw6 was decreased (9% versus 24% in controls, p less than 0.01). The relative risk for DR4 was 2.8, and the etiologic fraction was 0.33.(ABSTRACT TRUNCATED AT 250 WORDS)

Từ khóa


Tài liệu tham khảo

Thông tin
Thông tin xuất bản

Ovid Technologies (Wolters Kluwer Health)

Tập 83 Số 2

515-522

Thông tin tác giả